According to FDA-approved prescribing information for semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound), food intake does not significantly affect the absorption or efficacy of these subcutaneous injections
#Obesity #GLP1 #Healthcare #PatientCare #Medicine To view or add a comment, sign in Millions of older Americans with Medicare recently gained access to obesity drugs with a monthly copay of just $50
GLP-1 medications and TRT, when used appropriately and in combination with smart training and nutrition, offer a way to finally get unstuck
329,330 In degenerative joint diseases like OA, the metabolic balance of chondrocytes is disrupted, leading to the overproduction of degrading enzymes and inflammatory mediators, including iNOS, MMP-13, and ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5), which participate in cartilage degradation and inflammatory processes